One of the inflammatory factors affecting the prognosis of myocardial infarction is the high level of neutrophil count in the blood. In this study, we investigated the relationship of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in peripheral blood with ST-segment resolution and clinical outcomes of patients with ST-elevation myocardial infarction (STEMI) receiving thrombolytic therapy.
INTRODUCTION
Coronary artery diseases are among the most important pathogens and most common causes of death around the world that pose a heavy burden on healthcare systems of countries [1] . Myocardial infarction occurs as the result of the formation of a new blood clot on a platelet which is damaged by a chronic and inflammatory process known as atherosclerosis [2] . From among the numerous inflammatory factors which have been investigated as the determinant factors in the prognosis of myocardial infarction, the high level of neutrophil count in the blood has been found to be especially important [3, 4] . In addition, it has been demonstrated that peripheral lymphopenia in the course of myocardial infarction can be a sign of severe response to this disease and high level of cortisol secretion in the body [5] . Therefore, in recent years, the index of NLR, which represents the neutrophil to lymphocyte ratio in peripheral blood, has been used to identify the patients for whom the risk of mortality as the result of coronary diseases is relatively high [6] [7] [8] [9] [10] [11] . On the other hand, it has been found that the level of platelet in peripheral blood, besides being related to hemostasis, is also dependent on the serum level of inflammatory proteins such as CRP, interleukin 1, and interleukin 6 suggesting that higher platelet counts in the blood can be a symptom of a systemic inflammation [12] which itself is closely related to coronary diseases and atherosclerosis [2] . That is why the platelet to lymphocyte ratio (PLR) has also been considered in studies investigating various diseases including acute coronary syndrome [13, 14] and it has been demonstrated that in STEMI patients under treatment with primary PCI, the PLR in peripheral blood upon admission to hospital can be a determinant factor in the prognosis of mortality rate in hospital as well as during the 6 months after being discharged from the hospital [15] . However, the exact cause of the increase in mortality rate due to the increase in NLR and PLR indices has not been identified. 48 Considering the mechanism of action of thrombolytic therapy and the interconnection between coagulation and inflammatory systems of the body, determining the role of NLR and PLR in this type of therapy can lead to a better and faster identification of patients who are subject to greater risks of mortality and bring about a significantly positive change in the overall direction of their treatment. Moreover, the assessment of the clinical response to thrombolytic therapy, which is done via the analysis of ST-segment resolution (STR) in patients' electrocardiograms 90 minutes after the treatment and comparing them with the primary ones, can be a good indicator for the prognosis of myocardial infarction and restoring the blood flow in patients [16, 17] as previous studies have shown that the STR cut-off used </> 50% [18] . Bearing these in mind and considering the lack of adequate studies in this regard, we aimed to investigate the STEMI patients' response to thrombolytic therapy based on their STR level as revealed through electrocardiograms and clarify its relationship with NLR and PLR of their peripheral blood upon admission to the hospital.
MATERIALS AND METHODS
This study was a cross-sectional retrospective study in which retrospective methods of data collection were employed. In this study, the patients referring to the emergency department of one of the hospitals in Tabriz, Iran who were diagnosed with STEMI and began receiving treatment with reteplase in 12 hours after the start of symptoms and also had CBC test reports before receiving thrombolytic therapy entered the study. The inclusion criteria were being diagnosed with embolic STEMI, having CBC test report before receiving thrombolytic therapy, and also receiving reteplase in 12 hours after the start of symptoms. Patients having left bundle branch block or pacemaker, those consuming steroid medications, those suffering from chronic or acute inflammatory diseases or malignancies, and the ones receiving surgery during the last 3 months were excluded from the study. The selected patients were then assigned to different groups based on the level of response of STsegment to thrombolytic drug 90 minutes after its administration. The information about the demographic characteristics of the patients including their age, gender, and the risk factors of cardiovascular diseases such as the history of hyperlipidemia, diabetes, hypertension, family history of cardiovascular diseases, and smoking rate were gathered from the patients themselves. In this study, the major adverse cardiac events (MACE) score, which represents the major adverse cardiac events, was also evaluated. MACE has generally been defined as all-cause heart failure, mortality as the result of cardiac diseases, and reinfarction. However, reinfarction was omitted in this study. The factors which are considered in the calculation of this score for patients are their previous disease history, electrocardiogram, age, number of risk factors, and troponin level. Before the beginning of treatment with fibrinolytic drugs, the needed tests were conducted on all patients and their NLR and PLR were calculated. Moreover, the incidence rate of systolic heart failure with the ejection fraction of less than 45% as well as the in-hospital mortality rate was investigated. The data obtained from the patients were fed into SPSS Version 19 and then analyzed to reveal any possible relationship between different variables.
RESULTS
This study was conducted on 317 patients diagnosed with STEMI. First, the patients were divided into 3 groups based on the level of response of ST-segment to thrombolytic therapy. Patients with STR of lower than 50% (STR < 50%) were assigned to one group, those whose STR was in the range of 50%-70% (51% < STR < 70%) fell in another group, and those with STR of higher than 70% (STR > 70%) comprised the third group. In each of the three groups, the patients' gender, age, dyslipidemia, hypertension, diabetes mellitus, and history of smoking were investigated and the results indicated that there is no significant difference between the groups as regards these factors (Tables  1-4) . During the hospitalization, the patients' ejection fraction, hemoglobin (after the administration of fibrinolytic drugs), cholesterol, triglyceride, and sugar levels were checked. The results showed that only in the level of ejection fraction is there a significant relationship among the three groups of patients. The relationship was such that patients with better response to fibrinolytic drugs had higher levels of ejection fraction (Table 1) . Moreover, the analysis of the relationship of both NLR and PLR with the level of response of ST-segment using linear regression revealed that there is no significant relationship between either of these variables and the patients' level of response to thrombolytic therapy ( Table 2) .
The patients were then divided into two groups: the first group consisted of patients whose STR was lower than 50% and the second one consisted of those whose STR was higher than 50%. The results of our analysis indicated that there is no significant difference between the patients of the two groups in their age, gender, and other cardiac risk factors. However, the incidence rates of heart failure (P = 0.001), in-hospital mortality (P < 0.001), and reduction of ejection fraction (P < 0.001) were significantly higher in the patients of the first group (patients whose STR was lower than 50%) compared to those in the other group. Analysis of the platelet and neutrophil levels in the patients' blood as well as of their NLR and PLR did not show a significant difference between the two groups ( Table 3 ). The results of logistic regression analysis of NLR, PLR, diabetes mellitus, hemoglobin level, neutrophil count, platelet count, and their relationship with STR revealed that none of these variables are significantly related to patients' response to thrombolytic therapy ( Table 4) . As for the analysis of ROC curve of the relationship of NLR and PLR with the level of response to thrombolytic therapy, the cut-off level of NLR was found to be 65% with an area under the curve of 0.590 ± 0.077 ( Figure 1 ) and that of PLR was found to be 30% with an area under the curve of 0.500 ± 0.080 (Figure 2) .
In this study, MACE was observed in 47 patients. The analysis of data and the investigation of the different variables after the incidence of MACE demonstrated that only ejection fraction in these patients is significantly lower than that of the other patients (P < 0.001) and other variables do not have a significant relationship with its incidence (Table 5 ). Table 5 shows that NLR was significantly different between MACE positive and MACE negative patients and logistic regression analysis proved its independent role in predicting in-hospital MACE following MI (Table 6 ). 135.97 ± 55.03 0.030* Quantitative and qualitative data are represented as mean ± SD and frequency (Percent). *P-value was reported based on ANOVA. **P-value was reported based on Chi-Square test. P < 0.05 statistically significant. 0.387* Quantitative and qualitative data are represented as mean ± SD and frequency (Percent).*P-value was reported based on Independent samples t-tests. **P-value was reported based on Chi-Square test. P < 0.05 statistically significant Table 6 Logistic regression analysis to determine the risk factors for predicting MACE incidence after receiving thrombolytic therapy
Variables
Odds Ratio 95% confidence interval P value NLR 1.198 1.034-1.388 0.016* NLR: Neutrophil-to-lymphocyte ratio; *P < 0.05 statistically significant. According to the results presented in Table 5 , the only NLR variable between the MACE Positive and MACE Negative groups was significant, only this variable was introduced into the logistic regression analysis and was recognized as a risk factor for MACE infection.
DISCUSSION
The results of this study indicated that there is no significant relationship between either NLR or PLR and the response level to thrombolytic therapy in patients with myocardial infarction. However, the results of analysis with t-test and logistic regression showed that higher NLR increases the incidence risk of MACE. Also, the results of logistic regression analysis revealed that a lower PLR, too, leads to an increase in the incidence risk of MACE. In line with the findings of the present study, Cutlip et al. in their meta-analytic study observed that an increase in NLR leads to an increase in the risk of mortality in patients with cardiovascular events [19] . In another study, Park et al. reported that the deceased patients have higher neutrophil count (P = 0.061), lower lymphocyte count (P = 0.39), and higher NLR (P = 0.001), which are consistent with our findings. No significant relationship was observed between leukocyte profile and patient outcomes in their study. The best cutoff value of NLR for the prognosis of mortality was 5.44 and the NLR values higher than this (NLR > 5.44) increased the risk of mortality in patients [20] . Horne et al. also investigated NLR and reported that there is a relationship between relatively low lymphocyte counts and undesirable clinical outcomes in patients and that the cut-off value of 4.71 for NLR can be a predictor of patients' survival [4] . In line with the studies mentioned, Kaya et al. found that an increase in NLR raises the incidence rate of in-hospital thrombosis and nonfatal myocardial infarction and also increases mortality rate [9] . Furthermore, Ghaffari et al. reported that an increase in each of the variables of leukocyte count (P < 0.03), neutrophil count (P < 0.03), and NLR (P = 0.01) can be a predictor of heart failure in patients [11] . In another study conducted by Shin et al., it was observed that patients with NLR values higher than 6.3 are subject to greater risks of mortality and MACE during the first 24 hours after the start of symptoms, but, it was also reported that it cannot affect the incidence rate of reinfarction, stent thrombosis, and stroke [21] . However, in another study, Smit et al. reported that the leukocyte profile of patients upon admission to hospital does not have any significant relationship with their one-year mortality [22] . The analysis of the vast majority of studies in this area suggests that lymphocyte, neutrophil, and platelet profiles can have a significant role in the survival and clinical outcomes of patients with cardiac diseases. Therefore, the analysis of blood cells in such patients is particularly important. The present study also indicated that NLR is more likely to increase the incidence rate of adverse cardiac events, an observation which is consistent with the findings of the majority of studies conducted in this area.
CONCLUSION
The results of this study indicated that NLR and PLR are directly associated with the rate of inhospital major adverse effects following STEMI irrespective of the ST resolution. 
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